Metastatic Triple Negative Breast Cancer

Metastatic triple-negative breast cancer is an aggressive form of breast cancer that lacks three important receptors: estrogen, progesterone, and HER2. It tends to grow and spread quickly, making it difficult to treat. Chemotherapy is the primary treatment option for metastatic triple-negative breast cancer.

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

Trademark Disclaimer

WCG’s Clinical Trial Listing Service (CTLS) is an online database of clinical research studies curated from public and proprietary sources.

Any references to third-party entities, companies, brands, trademarks, service marks, or logos are provided solely for informational purposes. Such references do not imply any endorsement, sponsorship, authorization, recommendation, partnership, or other affiliation between WCG and any such third party.